Results 21 to 30 of about 14,308 (181)
Journal of the Formosan Medical Association, 2021 Background: Ropeginterferon alfa-2b is a novel mono-pegylated interferon that has only one major form as opposed to the 8 to 14 isomers of other on-market pegylated interferon products, allowing every-two-week injection with high tolerability.
Shih-Jer Hsu +15 more
doaj +1 more source
Thyrotoxicosis With Pegylated Interferon Alfa-2b [PDF]
Archives of Dermatology, 2010 Despite adequate surgery, a diagnosis of stage III melanoma carries a high risk of relapse, and hence mortality. Interferon alfa is the only treatment that has currently been shown to alter the natural history of the disease, delaying relapse-free survival, particularly in patients with micrometastatic disease.
Lowndes, SA, Asher, R, Middleton, MR
openaire +2 more sources
Onset of Celiac Disease after Treatment of Chronic Hepatitis C with Interferon Based Triple Therapy
Case Reports in Hepatology, 2015 Background. Patients treated with interferon (IFN) based therapies may develop exacerbation of autoimmune disease. We herein present the case of a 53-year-old female patient who developed celiac disease (CD) as a result of triple therapy (interferon ...
Amandeep Singh +2 more
doaj +1 more source
Журнал инфектологии, 2014 Combination therapy with pegylated interferon-α and ribavirin is the modern standard of chronic hepatitis C treatment [1-3] in Russian Federation [4]. This particular regimen provides achieving of sustained virological response (SVR) in 42-28% of patient
E. Z. Burnevich
doaj +1 more source
Safety and efficacy of nilotinib after 10 years of interferon
Clinical Management Issues, 2015 Here we describe a case of a woman with chronic myeloid leukemia at high risk, according to the Sokal Index. The patient started interferon alfa-2b (IFN) at standard dose obtaining a major molecular response after about four years of treatment.
Filippo Russo
doaj +1 more source
Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients. [PDF]
PLoS ONE, 2013 Interferon-based therapy (IBT) has been the standard of care for hepatitis C virus (HCV) infection. However, conflicting results exist regarding the effects of IBT on risk of developing hepatocellular carcinoma (HCC) and cirrhosis-associated ...
Ching-Sheng Hsu +6 more
doaj +1 more source
Arthritis &Rheumatology, EarlyView.Objective The unknown pathophysiology and the lack of specific features for systemic juvenile idiopathic arthritis and adult‐onset Still disease (collectively known as Still disease; SD) delay diagnosis and appropriate treatment. The goal of this study was to identify features and mechanisms that distinguish SD from other systemic autoinflammatory ...
Yvonne M. Mueller +16 more
wiley +1 more source
Using Recombinant Interferon Alpha-2b in Pediatric Practice
Zdorovʹe Rebenka, 2016 Interferon system is a key element of antiviral defense of the child’s body that etiopathogenetically justifies the use of nasal and rectal formulations of recombinant interferon alfa-2b for the prevention and treatment of acute respiratory viral ...
Yu.V. Marushko +2 more
doaj +1 more source
BMEMat, EarlyView.ZIF‐8‐based nanoparticles co‐delivering CB‐839 (glutaminase inhibitor) and 1‐MT (IDO1 inhibitor), dual‐targeting glutamine/tryptophan metabolism to induce immunogenic cell death, activate STING, block kynurenine production, reverse immunosuppression, and enhance cancer immunotherapy to suppress primary/distant tumors.
Wenli Ning +10 more
wiley +1 more source
Акушерство, гинекология и репродукция, 2019 Introduction. Preventing recurrent bacterial vaginosis (BV) during pregnancy is an important issue in current obstetrics.Aim: to assess the effect of recombinant human interferon alpha-2b on the incidence of recurrent BV during pregnancy and on the ...
A. V. Podgornaya +1 more
doaj +1 more source